Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2017 / Cilt: 50 Sayı: 3

Primary Mucosal Malignant Melanoma of the Nasolacrimal System

Nazolakrimal Sistemin Primer Mukozal Malign Melanomu

SÜMEYRA Doluoğlu(Ankara Numune Education and Research Hospital)
Aydın Acar(Ankara Numune Education and Research Hospital)
Serdar Özer(Ankara Numune Education and Research Hospital)
Gülüşan Ergül(Ankara Numune Education and Research Hospital)
Adil Eryılmaz(Ankara Numune Education and Research Hospital)
Pages
156–160
Publication Date
2017-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient is presented under the light of the relevant literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mucosal malignant melanoma of the nasolacrimal system is rare and usually has an aggressive clinical course.
📊
Key Findings & Data:Our case was a 92-year-old male who had presented with bloody lacrimation in the left eye for the previous three months and epistaxis for the previous two months.
💡
Conclusion & Impact:The patient is presented under the light of the relevant literature.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Malign melanom · nazolakrimal sistem · epistaksis

Abstract

Mucosal malignant melanoma of the nasolacrimal system is rare and usually has an aggressive clinical course. These tumors present themselves with epiphora, bloody tears and epistaxis, and as the tumor grows, with a mass. Regarding these tumors, the number of studies in the literature is relatively small in number. Our case was a 92-year-old male who had presented with bloody lacrimation in the left eye for the previous three months and epistaxis for the previous two months. The histopathological diagnosis of the biopsy obtained from the mass observed at the inferior meatus during nasal endoscopy was “Malignant melanoma of the nasolacrimal system”. The patient is presented under the light of the relevant literature.

Özet

Nazolakrimal sistemin mukozal malign melanomu nadir görülür ve son derece agresiv seyreder. Bu tümörler kendini epifora, kanlı gözyaşı, epistaksis ve tümör büyüdükçe de kitle oluşturarak belli eder. Literatür incelendiğinde bu tümörlere ait çalışmalar oldukça az sayıdadır. Bizim vakamız 3 aydır devam eden sol gözde kanlı sulanma ve 2 aydır burun kanaması şikayeti olan, 92 yaşında erkek hasta idi. Nazal endoskopide alt meatusta görülen kitleden alınan biyopsi ile nazolakrimal sistem malign melanomu tanısı konulup, literatür eşliğinde tartışılmıştır.

🔖

Cite This Article

Doluoğlu, S., Acar, A., Özer, S., Ergül, G., Eryılmaz, A. (2017). Primary Mucosal Malignant Melanoma of the Nasolacrimal System. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 50 Sayı: 3, 156–160. https://ajindex.com/articles/1363339

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Evans RD, Kopf AW, Lew RA et al. Risk factors for the development of malignant melanoma. I: review of the case-control studies. J Dermatol Surg Oncol. 1988;14:393-408.
  2. Snow G, Vander Waal I. Mucosal melanomas of the head and neck. Otolaryngol Clin North Am. 1986;19:537-547.
  3. Batsakis JG, Suarez P. Mucosal melanomas: a review. Adv Anat Pathol. 2000;7:167-180.
  4. Schroeder W. Intranasal melanoma. Mo Med. 1992;89:294-297.
  5. Yamade S, Kiragawa A. Malignant melanoma of the lacrimal sac. Ophthalmologica. 1978;177:30-33.
  6. Levine MR, Dinar Y, Davies R. Malignant melanoma of the lacrimal sac. Ophthalmic Surg Lasers. 1996;27:318-320.
  7. Briele H, Walker M, Das Gupta T. Melanoma of the head and neck. Clin Plast Surg. 1985;12:495-503.
  8. Zak F, Lawson W. The presence of melanocytes in the nasal cavity. Ann Otolaryngol. 1974;83:515-519.
  9. Conley J, Pack G. Melanoma of the mucous membranes of the head and neck. Arch Otolaryngol. 1974;99:315-319.
  10. Holmstrom M, Lund V. Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med. 1991;48:9-11.
  11. Holdcraft J, Gallagher J. Malignant melanomas of the nasal and paranasal sinus mucosa. Ann Otolaryngol Rhinol Laryngol. 1969;78:1-20.
  12. Pe’er JJ, Stefanysyn M, Hidayat AA. Nonepithelial tumours of the lacrimal sac. Am J Ophthalmol. 1994;118:650-658.
  13. Stefanysyn MA, Hidayat AA, Pe’er JJ, Flanagan JC. Lacrimal sac tumours. Ophthalmic Plast Reconstr Surg. 1994;10:169-184.
  14. Esteban F, Gonzalez-Perez JM, Benaıxa JP et al. Malignant melanomas of the nasolacrimal duct. The J Laryng Otology. 2007;121:285-288.
  15. Lewis AM, Clarke PM, Olver JM. Primary nasolacrimal duct malignant mucosal melanoma. Br J Ophthalmol. 2006;90:114-115.
  16. Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg. 2003;129:864-868.
  17. Lund V, Howard D, Harding L, Wei WI. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope. 1999;109:208-211.
  18. Gilligan D, Slevin N. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol. 1991;64:1147-1150.
  19. Seo W, Ogasawara H, Sakagani M. Chemohormonal therapy for malignant melanomas of the nasal and paranasal mucosa. Rhinology. 1997;35:19-21.
  20. Owens RM, Wax MK, Kostik D, Linberg JV, Hogg J. Malignant melanoma of the lacrimal sac. Otolaryngol Head Neck Surg. 1995;113:634-640.